PerkinElmer Launches New MicroBeta2 Microplate Counter Platform
Industry leader in automation and detection announces newest
MicroBeta(R) line for assay development, screening and profiling in drug
discovery and basic research
WALTHAM, Mass., Jan 14, 2009 (BUSINESS WIRE) --
PerkinElmer,
Inc., a global leader focused on the health and safety of people and
the environment, today announced the launch of its MicroBeta2
microplate counter platform, for enabling improved radiometric and
luminescent detection in drug discovery and basic life science research.
The MicroBeta2
and MicroBeta2
LumiJET systems are the latest versions of PerkinElmer's MicroBeta(R)
line and add new and improved capabilities for researchers engaged in
all major radiometric and luminescence applications. The MicroBeta2
platform is designed for robust performance with both radiometric and
glow luminescent assays.
Sensitive detection is achieved through coincidence counting, for high
efficiency and extremely low background for a wide variety of
radionuclides. By combining liquid scintillation counter reliability
with plate reader simplicity, the system allows significant savings in
time and consumables, while reducing waste.
"The newest version of the MicroBeta2 system further provides
researchers with an entry path to the benefits of luminescent-based
technologies in addressing many potential drug targets," said Richard M.
Eglen, Ph.D., president, Bio-discovery, PerkinElmer. "Leveraging
PerkinElmer's long leadership in radiometric detection solutions, the
MicroBeta2 platform further represents a flexible system for
either radiometric detection, or luminescent drug discovery assays."
The MicroBeta2 LumiJET Microplate Counter provides the assay
development and profiling capabilities that pharma, biotech and academic
customers require for luminescent assay platforms. The MicroBeta2
LumiJET system uses well-validated PerkinElmer technology to enable
best-in-class measurement of flash and glow luminescent technologies
including Aequorin/Ca2+ (PerkinElmer's AequoScreen(R)
and PhotoScreen(R)
technology, respectively) measurement and dual label reporter gene
assays, as well as classical GPCR filtration assays and scintillation
proximity assays.
Key features of the MicroBeta2 Liquid Scintillation Counting
(LSC) and Luminescence readers include:
-
Improved flexibility and throughput with a choice of multiple
detectors (1, 2, 6 or 12) with two reagent dispensing heads per
detector for more efficient assay development with flash luminescence
technology such as Aequorin.
-
True coincidence detection for liquid scintillation counting of all
common radiolabels in a variety of formats including liquids, filter
and solid phase samples.
-
New top-read mode for Time-resolved Liquid Scintillation Counting
(TR-LSC) counting delivers improved detection with numerous microplate
lines - including FlashPlates(R), Unifilter(R) Plates and LumaPlates(TM)
-
Improved user interface, factory preset protocols and live kinetic
display
Unifilter is a registered trademark of Whatman International Ltd. About PerkinElmer, Inc. PerkinElmer, Inc. is a global leader focused on improving the health and
safety of people and their environment. The Company reported revenue of
$1.8 billion in 2007, has approximately 9,100 employees serving
customers in more than 150 countries, and is a component of the S&P 500
Index. Additional information is available through www.perkinelmer.com
or 1-877-PKI-NYSE.
SOURCE: PerkinElmer, Inc.
PerkinElmer, Inc.
Mario R. Fante, 781-663-5602
mario.fante@perkinelmer.com
Copyright Business Wire 2009
News Provided by COMTEX
| 
